Integrated care pathway for co-occurring major depressive and alcohol use disorders: Outcomes of the first two years.
Andriy V SamokhvalovSaima AwanTony P GeorgeJulie IrvingBernard Le FollSteve PerrottaCharlotte ProbstPeter VooreJürgen RehmPublished in: The American journal on addictions (2017)
The ICP patients demonstrated improvements on several levels including depressive symptoms, and changes in alcohol drinking patterns. The study demonstrated the overall effectiveness of the ICP and apparent advantage over TAU, which must be corroborated through a randomized clinical trial. (Am J Addict 2017;26:602-609) SCIENTIFIC SIGNIFICANCE: This study is one of the first works showing the outcomes of an ICP developed in the mental health area and for co-occurring disorders. Despite the limitations, the relative advantage of the ICP methodology warrants future research in this area.
Keyphrases
- mental health
- depressive symptoms
- end stage renal disease
- randomized controlled trial
- systematic review
- healthcare
- palliative care
- ejection fraction
- chronic kidney disease
- newly diagnosed
- type diabetes
- prognostic factors
- peritoneal dialysis
- metabolic syndrome
- computed tomography
- insulin resistance
- current status
- weight loss
- cerebrospinal fluid